Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist PegvisomantPeter Trainer, John A. Scarlett, William M Drake et al.|New England Journal of Medicine|2000Cited by 874
[11C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trialXilin Wu, Morris J. Brown, Russell Senanayake et al.|Nature Medicine|2023Cited by 137
Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopauseMorris J. Brown, Elena Azizan, Claudia Cabrera et al.|Nature Genetics|2021Cited by 88
Modeling Congenital Adrenal Hyperplasia and Testing Interventions for Adrenal Insufficiency Using Donor-Specific Reprogrammed CellsGerard Ruiz‐Babot, Leonardo Guasti, Mariya Balyura et al.|Cell Reports|2018Cited by 64
Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohortJun Yang, Mitsuhide Naruse, Xi‐Lin Wu et al.|The Lancet Diabetes & Endocrinology|2025Cited by 53